Addressing Current Gaps and Unmet Needs GLP-1R agonists have rapidly evolved from glucose-lowering agents for T2DM to multifaceted therapeutics with FDA- and EMA-approved indications for obesity, cardiovascular disease, chronic kidney disease, diabetic nephropathy, and sleep apnea
Physicians and staff should understand hair-cycle biology, diffuse alopecia, trichoscopy, donor safety, nutritional contributors, medical therapy, shock loss, graft handling and expectation management
It is responsible for maintaining blood pressure and total fluid volume
Increased oxidative stress, inflammation and lipotoxicity associated with hyperglycaemia and insulin resistance potentially impair vascular endothelial function and increase endothelial permeability, leading to the penetration of glycated and oxidized low-density lipoprotein (LDL) cholesterol into the endothelium, i.e., initiation of atherosclerosis
As shown in (Fig
I would like to understand your story and obesity
